Parul S. Patel, M.D., Scientist; Transplant Nephrologist at CPMC

California Pacific CURRENTS: The online journal of CPMC Research Institute

Leading new advances in the treatment of kidney disease; improving outcomes after kidney transplantation

Research Overview

  • A member of CPMC's kidney transplant team, Dr. Patel is a leading expert in the management of kidney disease. He is board certified in nephrology.
  • Dr. Patel investigates the immune response after kidney transplantation; continuous renal replacement therapies; and new strategies to promote graft success and limit acute organ rejection after kidney transplant.
  • He is a co-investigator of clinical trials assessing the safety and efficacy of novel therapies in kidney transplant patients.

Training

Dr. Patel received his M.D. from Baylor College of Medicine in Houston, Texas. He completed residency training in internal medicine and fellowships in transplant medicine and nephrology at Baylor College of Medicine and at Beth Israel Deaconess Medical Center in Boston.  He was previously on faculty as an Assistant Professor in medicine and nephrology at Baylor College of Medicine and Boston University Medical Center.


 

Publication Search

Publications

Markowitz M, Frank I, Grant RM, Mayer KH, Elion R, Goldstein D, Fisher C, Sobieszczyk ME, Gallant JE, Van Tieu H, Weinberg W, Margolis DA, Hudson KJ, Stancil BS, Ford SL, Patel P, Gould E, Rinehart AR, Smith KY, Spreen WR, Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. Lancet HIV

Moynahan ME, Chen D, He W, Sung P, Samoila A, You D, Bhatt T, Patel P, Ringeisen F, Hortobagyi GN, Baselga J, Chandarlapaty S, Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2. Br J Cancer

Trezza C, Ford SL, Gould E, Lou Y, Huang C, Ritter JM, Buchanan AM, Spreen W, Patel P, Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women. Br J Clin Pharmacol

Hsieh JJ, Chen D, Wang PI, Marker M, Redzematovic A, Chen YB, Selcuklu SD, Weinhold N, Bouvier N, Huberman KH, Bhanot U, Chevinsky MS, Patel P, Pinciroli P, Won HH, You D, Viale A, Lee W, Hakimi AA, Berger MF, Socci ND, Cheng EH, Knox J, Voss MH, Voi M, Motzer RJ, Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Eur Urol

Chandarlapaty S, Chen D, He W, Sung P, Samoila A, You D, Bhatt T, Patel P, Voi M, Gnant M, Hortobagyi G, Baselga J, Moynahan ME, Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial. JAMA Oncol

VIEW ALL
Parul S. Patel, M.D., Scientist; Transplant Nephrologist at CPMC
Primary Research Interests
  • Nephrology
  • Kidney transplantation